Search Results

LDN-193189 5mg  | 98.98%

APEXBIO TECHNOLOGY LLC

ALK inhibitor,potent and selective TGF-β / Smad Signaling|SMAD

More Information Supplier Page

×

LDN-193189

LDN-193189 10mg  | 98.98%

APEXBIO TECHNOLOGY LLC

ALK inhibitor,potent and selective TGF-β / Smad Signaling|SMAD

More Information Supplier Page

×

LDN-193189

LDN-193189 50mg  | 98.98%

APEXBIO TECHNOLOGY LLC

ALK inhibitor,potent and selective TGF-β / Smad Signaling|SMAD

More Information Supplier Page

×

LDN-193189

Neratinib (HKI-272) 25mg  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)

WP1130 10mM (in 1mL DMSO)  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

WP1130 Evaluation Sample  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

WP1130 5mg  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

WP1130 10mg  | 99.2%

APEXBIO TECHNOLOGY LLC

Deubiquitinase (DUB) inhibitor, Cell permeable Ubiquitination/ Proteasome|DUB

More Information Supplier Page

×

WP1130

Neratinib (HKI-272) 5mg  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)

Neratinib (HKI-272) Evaluation Sample  | 99.81%

APEXBIO TECHNOLOGY LLC

HER2/EGFR inhibitor,potent and irreversible JAK/STAT Signaling|EGFR

More Information Supplier Page

×

Neratinib (HKI-272)